Trump wants pharmaceutical companies to cut the cost of drugs for Americans - but industry bosses warn this puts the UK's ...

TRENTON, N.J. (AP) -- Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and mov ...

AstraZeneca ’s AZN 3.11% longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and Presiden… ...

AstraZeneca announced plans to invest $50 billion in the U.S., making it the latest company to pour money into the American economy under the Trump administration.

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition. Find out why AZN stock is a hold.

The European Commission (EC) has approved the combination antibiotic ceftazidime/avibactam (Zavicefta, AstraZeneca) for the treatment of patients with serious Gram-negative bacterial infections ...